Connection Between Epigenome, Selective Mutability, Evolution, and Human Disease
Li, Harris et al., PLoS Genetics
Researchers at the Baylor College of Medicine and elsewhere propose a "connection between the epigenome, selective mutability, evolution, and human disease" based on the findings of their study on associations of structural mutability with germline DNA methylation and with non-allelic homologous recombination mediated by low-copy repeats. "Combined evidence from four human sperm methylome maps, human genome evolution, structural polymorphisms in the human population, and previous genomic and disease studies consistently points to a strong association of germline hypomethylation and genomic instability," the Baylor-led team writes.
Adding Alzheimer's Risk Option, 23andMe Revives Questions on Utility of DTC Genomics
April 20, 2011
The "opt-in" model ensures that customers are aware of the risks and limitations of this potentially sensitive data, but some are questioning whether the direct-to-consumer model is the appropriate mechanism for delivering information on APOE status, even with additional precautions.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.
New to GenomeWeb? Register quickly here.
Related Stories
- Duke University Keeping an Eye on DTC Genomics Firms that Might be Infringing its APOE Patents
April 27, 2011 / Pharmacogenomics Reporter - Takeda to Use Zinfandel's TOMM40 Test in Alzheimer's Development Program for Actos
January 12, 2011 / Pharmacogenomics Reporter - CDC Advises Docs to Inform Patients of Limitations of DTC Gene Scans
August 11, 2010 / Pharmacogenomics Reporter - DTC Genomics Gets Time Before FDA as Agency Considers Regulatory Strategy
July 21, 2010 / Pharmacogenomics Reporter - Brain Imaging, Cognitive Evaluation Link TOMM40 Alterations to Alzheimer's Risk in Healthy Patients
July 14, 2010 / Pharmacogenomics Reporter